跳至主要內容

藥品參考

Tislelizumab

Tislelizumab is a medicine in the class oncology. It is used for gastric cancer.

最後更新 來源: EMA SmPC

僅供醫療專業人員參考。本頁為簡要摘要,並非醫療建議,亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。

本頁的臨床內容僅提供英文版。

重點資訊

藥物類別
Oncology
ATC 代碼
L01FF09
常見劑型
注射劑
常見規格
10 mg/ml
已知交互作用
6 (中度: 5 · 輕微: 1)
商品名
2
國家與市場
2

劑型、規格與商品名稱會因國家而異。請核對您手上的產品。

用途

作用方式

Humanised IgG4 variant monoclonal antibody against PD-1 that binds the extracellular domain of human PD-1 and competitively blocks binding of PD-L1 and PD-L2. This inhibits PD-1-mediated negative signalling and enhances T-cell functional activity in in vitro assays.

成人常用劑量(仿單摘要)

Monotherapy: 200 mg once every 3 weeks or 400 mg once every 6 weeks, intravenous infusion; treat until disease progression or unacceptable toxicity

僅摘錄仿單中第一行劑量說明;完整的劑量內容請見 App。

懷孕與哺乳

懷孕
Unsafe No data in pregnant women; can cause foetal harm based on its mechanism of action. Do not use during pregnancy unless the woman's clinical condition requires treatment.
哺乳
Unsafe Unknown whether excreted in human milk; women should not breast-feed during treatment and for at least 4 months after the last dose.

已通報的副作用

  • Anaemia
  • Aspartate aminotransferase increased
  • Fatigue
  • Alanine aminotransferase increased
  • Neutropenia (with chemotherapy)
  • Thrombocytopenia (with chemotherapy)

禁忌症

  • Hypersensitivity to the active substance or to any excipient.

哪些人需要特別留意

  • Immune-related adverse reactions, including fatal cases, can affect any organ system and may occur after the last dose; evaluate and withhold, with corticosteroids as needed.
  • Immune-related pneumonitis, including fatal cases; monitor for signs and symptoms.
  • Immune-related hepatitis; perform liver function tests at baseline and periodically.

請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏,以及您正在使用的所有其他藥物或保健品。

重要交互作用 (6)

Pro+ 會員專屬

解鎖完整頁面

建立帳號並開始 Pro+ 試用,即可開啟 Tislelizumab 的完整藥品專論:劑量、懷孕與哺乳、副作用、警示及所有交互作用。

  • Dosing by age, kidney and liver function, and further dose lines
  • Renal and hepatic dose adjustments
  • Dosing in older adults
  • How to give it
  • Pharmacokinetics
  • Patient counselling points

在網頁版免費試用 Pro+ 14 天,無需信用卡。

同類別的其他藥品

常見問題

What is Tislelizumab used for?

Tislelizumab is a medicine in the class oncology. It is used for Gastric cancer, Lung cancer, Non-small cell lung cancer, Squamous cell carcinoma.

What side effects have been reported with Tislelizumab?

Anaemia, Aspartate aminotransferase increased, Fatigue, Alanine aminotransferase increased, Neutropenia (with chemotherapy), Thrombocytopenia (with chemotherapy).

Can Tislelizumab be taken in pregnancy or while breastfeeding?

Pregnancy: Unsafe. No data in pregnant women; can cause foetal harm based on its mechanism of action. Do not use during pregnancy unless the woman's clinical condition requires treatment. Breastfeeding: Unsafe. Unknown whether excreted in human milk; women should not breast-feed during treatment and for at least 4 months after the last dose.

What does Tislelizumab interact with?

MediHelp lists 6 known interactions for Tislelizumab. Moderate: 5 · Minor: 1. The most serious include Amoxicillin, Amoxicillin-clavulanic acid, Piperacillin.

在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查

在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用,並使用劑量工具。

依 A–Z 瀏覽 · 藥品參考

取得 App 登入